Trial Profile
Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Oct 2023
Price :
$35
*
At a glance
- Drugs Erenumab (Primary) ; Siltuximab (Primary)
- Indications Neurilemmoma; Pain
- Focus Therapeutic Use
- Acronyms STARFISH
- 06 Oct 2023 Status changed from not yet recruiting to recruiting.
- 16 Jan 2023 New trial record